Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 5:31 pm Unchanged | 2022-02-14 | 13G | Korro Bio, Inc. KRRO | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:30 pm Unchanged | 2022-02-14 | 13G | RAPT Therapeutics, Inc. RAPT | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:30 pm Unchanged | 2022-02-14 | 13G | SCYNEXIS, Inc. SCYX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:28 pm Unchanged | 2022-02-14 | 13G | Tarsus Pharmaceuticals, Inc. TARS | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:20 pm Unchanged | 2022-02-14 | 13G | C4 Therapeutics, Inc. CCCC | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:18 pm Unchanged | 2022-02-14 | 13G | ROCKET PHARMACEUTICALS INC WT RCKTW | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:18 pm Unchanged | 2022-02-14 | 13G | Provention Bio, Inc. PRVB | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:15 pm Unchanged | 2022-02-14 | 13G | Research Alliance Corp. II RACB | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:11 pm Unchanged | 2022-02-14 | 13G | Rain Enhancement Technologies Holdco Inc RAIN | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 5:05 pm Unchanged | 2022-02-14 | 13G | Forte Biosciences, Inc. FBRX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:57 pm Unchanged | 2022-02-14 | 13G | IsoPlexis Corporation ISO | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:50 pm Unchanged | 2022-02-14 | 13G | Travere Therapeutics, Inc. TVTX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:48 pm Unchanged | 2022-02-14 | 13G | Prometheus Biosciences, Inc. RXDX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:40 pm Unchanged | 2022-02-14 | 13G | BELLUS Health Inc. BLU | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:38 pm Unchanged | 2022-02-14 | 13G | enVVeno Medical Corporation NVNO | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:10 pm Unchanged | 2022-02-14 | 13G | Albireo Pharma, Inc. ALBO | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 4:01 pm Unchanged | 2022-02-14 | 13G | Neptune Wellness Solutions Inc. NEPT | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 3:57 pm Unchanged | 2022-02-14 | 13G | Agile Therapeutics, Inc. AGRX | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 3:54 pm Unchanged | 2022-02-14 | 13G | Verrica Pharmaceuticals Inc. VRCA | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-14 3:50 pm Unchanged | 2022-02-14 | 13G | Global Blood Therapeutics, Inc. GBT | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |